IBDEI0AX ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4745,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4745,1,4,0)
 ;;=4^724.2
 ;;^UTILITY(U,$J,358.3,4745,1,5,0)
 ;;=5^LUMBAGO
 ;;^UTILITY(U,$J,358.3,4746,0)
 ;;=272.4^^23^242^62
 ;;^UTILITY(U,$J,358.3,4746,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4746,1,4,0)
 ;;=4^272.4
 ;;^UTILITY(U,$J,358.3,4746,1,5,0)
 ;;=5^HYPERLIPIDEMIA NEC/NOS
 ;;^UTILITY(U,$J,358.3,4747,0)
 ;;=724.5^^23^242^11
 ;;^UTILITY(U,$J,358.3,4747,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4747,1,4,0)
 ;;=4^724.5
 ;;^UTILITY(U,$J,358.3,4747,1,5,0)
 ;;=5^BACKACHE NOS
 ;;^UTILITY(U,$J,358.3,4748,0)
 ;;=702.0^^23^242^1
 ;;^UTILITY(U,$J,358.3,4748,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4748,1,4,0)
 ;;=4^702.0
 ;;^UTILITY(U,$J,358.3,4748,1,5,0)
 ;;=5^ACTINIC KERATOSIS
 ;;^UTILITY(U,$J,358.3,4749,0)
 ;;=719.40^^23^242^74
 ;;^UTILITY(U,$J,358.3,4749,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4749,1,4,0)
 ;;=4^719.40
 ;;^UTILITY(U,$J,358.3,4749,1,5,0)
 ;;=5^JOINT PAIN-UNSPEC
 ;;^UTILITY(U,$J,358.3,4750,0)
 ;;=380.4^^23^242^66
 ;;^UTILITY(U,$J,358.3,4750,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4750,1,4,0)
 ;;=4^380.4
 ;;^UTILITY(U,$J,358.3,4750,1,5,0)
 ;;=5^IMPACTED CERUMEN
 ;;^UTILITY(U,$J,358.3,4751,0)
 ;;=727.3^^23^242^20
 ;;^UTILITY(U,$J,358.3,4751,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4751,1,4,0)
 ;;=4^727.3
 ;;^UTILITY(U,$J,358.3,4751,1,5,0)
 ;;=5^BURSITIS NEC
 ;;^UTILITY(U,$J,358.3,4752,0)
 ;;=389.9^^23^242^59
 ;;^UTILITY(U,$J,358.3,4752,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4752,1,4,0)
 ;;=4^389.9
 ;;^UTILITY(U,$J,358.3,4752,1,5,0)
 ;;=5^HEARING LOSS NOS
 ;;^UTILITY(U,$J,358.3,4753,0)
 ;;=274.9^^23^242^57
 ;;^UTILITY(U,$J,358.3,4753,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4753,1,4,0)
 ;;=4^274.9
 ;;^UTILITY(U,$J,358.3,4753,1,5,0)
 ;;=5^GOUT NOS
 ;;^UTILITY(U,$J,358.3,4754,0)
 ;;=729.2^^23^242^79
 ;;^UTILITY(U,$J,358.3,4754,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4754,1,4,0)
 ;;=4^729.2
 ;;^UTILITY(U,$J,358.3,4754,1,5,0)
 ;;=5^NEURALGIA/NEURITIS/RADICULITIS
 ;;^UTILITY(U,$J,358.3,4754,2)
 ;;=^82605
 ;;^UTILITY(U,$J,358.3,4755,0)
 ;;=366.9^^23^242^22
 ;;^UTILITY(U,$J,358.3,4755,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4755,1,4,0)
 ;;=4^366.9
 ;;^UTILITY(U,$J,358.3,4755,1,5,0)
 ;;=5^CATARACT NOS
 ;;^UTILITY(U,$J,358.3,4756,0)
 ;;=278.00^^23^242^81
 ;;^UTILITY(U,$J,358.3,4756,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4756,1,4,0)
 ;;=4^278.00
 ;;^UTILITY(U,$J,358.3,4756,1,5,0)
 ;;=5^OBESITY, UNSP
 ;;^UTILITY(U,$J,358.3,4757,0)
 ;;=365.9^^23^242^56
 ;;^UTILITY(U,$J,358.3,4757,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4757,1,4,0)
 ;;=4^365.9
 ;;^UTILITY(U,$J,358.3,4757,1,5,0)
 ;;=5^GLAUCOMA NOS
 ;;^UTILITY(U,$J,358.3,4758,0)
 ;;=496.^^23^242^39
 ;;^UTILITY(U,$J,358.3,4758,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4758,1,4,0)
 ;;=4^496.
 ;;^UTILITY(U,$J,358.3,4758,1,5,0)
 ;;=5^COPD
 ;;^UTILITY(U,$J,358.3,4759,0)
 ;;=437.9^^23^242^23
 ;;^UTILITY(U,$J,358.3,4759,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4759,1,4,0)
 ;;=4^437.9
 ;;^UTILITY(U,$J,358.3,4759,1,5,0)
 ;;=5^CEREBROVASC DISEASE NOS
 ;;^UTILITY(U,$J,358.3,4760,0)
 ;;=780.4^^23^242^45
 ;;^UTILITY(U,$J,358.3,4760,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4760,1,4,0)
 ;;=4^780.4
 ;;^UTILITY(U,$J,358.3,4760,1,5,0)
 ;;=5^DIZZINESS AND GIDDINESS
 ;;^UTILITY(U,$J,358.3,4761,0)
 ;;=332.0^^23^242^84
 ;;^UTILITY(U,$J,358.3,4761,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4761,1,4,0)
 ;;=4^332.0
 ;;^UTILITY(U,$J,358.3,4761,1,5,0)
 ;;=5^PARKINSON'S DISEASE
 ;;^UTILITY(U,$J,358.3,4762,0)
 ;;=356.9^^23^242^87
 ;;^UTILITY(U,$J,358.3,4762,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI0AX
